This is a good point. If we could avoid massive expansion of arbitrary and innovation-killing biotech regulations, then the market will eventually correct the c

This is a good point. If we could avoid massive expansion of arbitrary and innovation-killing biotech regulations, then the market will eventually correct the current shortcomings and will catch up and work within the current framework. This will lower costs and drive up quality of care. Silicon Valley potentially has an important role to play here.